Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clinical trial NCT01718353 · COMPLETED
Trial details
- NCT number
- NCT01718353
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2015-08-01
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.